WEBINAR: Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. With a growing number of available assays and more labs offering testing, it is essential to have consistency in reporting and the ability to compare results and validate current or new methods.

This webinar will feature a panel of experts in the field who will provide key insights into the current needs in prenatal testing, the complexities of selecting an assay format and performing quality control, as well as other challenges that labs face when setting up and validating an NIPT assay. 

 

We’re committed to your privacy. SeraCare will not share or sell your data. View our privacy policy below for details.